David T. Davies - Concepedia

Author

David T. Davies

Also Known As

D. DAVIES, D. T. DAVIES, D.T. Davies, DAVID T. DAVIES, David Davies, David T Davies, David T. Davies, David T. Davies, Davies, D.T., Davies, David

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United Kingdom)GlaxoSmithKline (United States)South College University of Siena GlaxoSmithKline (Spain)

About

David T. Davies is an author at GlaxoSmithKline (United Kingdom) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	630
2	Natural Sciences	10	10	450
3	Biochemistry	8	8	366
4	Engineering	5	5	150
5	Health Sciences	2	2	96

David T. Davies

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Discovery of a Novel Metallo-β-Lactamase Inhibitor That Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacteriaceae Martin Everett, Nicolas Sprynski, Alicia Coelho, Antimicrobial Agents and Chemotherapy	2018	94
Biarylcarbamoylindolines Are Novel and Selective 5-HT<sub>2C</sub> Receptor Inverse Agonists: Identification of 5-Methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]- 5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a Potential Antidepressant/Anxiolytic Agent Steven M. Bromidge, Steven Dabbs, David T. Davies, Journal of Medicinal Chemistry Potential Antidepressant/anxiolytic AgentPsychotropic MedicationInverse AgonistsPharmacotherapyNew Series	2000	79
Design, synthesis and structure–activity relationships of substituted oxazole–benzamide antibacterial inhibitors of FtsZ Neil R. Stokes, Nicola Baker, James M. Bennett, Bioorganic & Medicinal Chemistry Letters Antimicrobial Drug DiscoveryBiochemistryMedicineAntibacterial InhibitorsOrganic Chemistry	2013	78
Novel and Selective 5-HT<sub>2C/2B</sub> Receptor Antagonists as Potential Anxiolytic Agents: Synthesis, Quantitative Structure−Activity Relationships, and Molecular Modeling of Substituted 1-(3-Pyridylcarbamoyl)indolines Steven M. Bromidge, Steven Dabbs, David T. Davies, Journal of Medicinal Chemistry Biological ActivityMolecular PharmacologyMedicinal ChemistryPotential Anxiolytic AgentsBiochemistry	1998	64
Novel hydroxyl tricyclics (e.g., GSK966587) as potent inhibitors of bacterial type IIA topoisomerases Timothy J. Miles, Alan J. Hennessy, B.D. Bax, Bioorganic & Medicinal Chemistry Letters Inhibitory ActivityMedicinal ChemistryMedicineNatural SciencesNovel Hydroxyl Tricyclics	2013	63
Preparation of N-Heterocycles by Radical Cyclisation of Enamides Mediated by Manganese(III) or Copper(I). A Comparison of Cyclisation Methods David T. Davies, Neha Kapur, Andrew F. Parsons Tetrahedron Radical CyclisationChemical EngineeringCyclisation MethodsEngineeringHeterocyclic	2000	60
Pyridine-3-carboxamide-6-yl-ureas as novel inhibitors of bacterial DNA gyrase: Structure based design, synthesis, SAR and antimicrobial activity Ian A. Yule, Lloyd G. Czaplewski, Stéphanie Pommier, European Journal of Medicinal Chemistry BiochemistryMedicineNatural SciencesBacterial Dna GyraseAntimicrobial Activity	2014	56
SAR Studies Leading to the Identification of a Novel Series of Metallo-β-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model Simon Leiris, Alicia Coelho, Jérôme Castandet, ACS Infectious Diseases Metallo-β-lactamase InhibitorsPharmacotherapyAntimicrobial ChemotherapyAntibiotic ResistanceBacterial Pathogens	2018	53
The Chemistry of Pseudomonic Acid. 15. Synthesis and Antibacterial Activity of a Series of 5-Alkyl, 5-Alkenyl, and 5-Heterosubstituted Oxazoles Pamela Brown, David T. Davies, Peter J. O'Hanlo, Journal of Medicinal Chemistry Bioorganic Chemistry5-Heterosubstituted OxazolesAntibacterial ActivityNatural SciencesOrganic Chemistry	1996	50
Novel cyclohexyl-amides as potent antibacterials targeting bacterial type IIA topoisomerases Timothy J. Miles, Christopher W. Barfoot, Gerald Brooks, Bioorganic & Medicinal Chemistry Letters MedicineNovel Cyclohexyl-amidesAntibacterial AgentAntimicrobial ChemotherapyMicrobiology	2011	49

Page 1